Alvogen acquires Korean Dream Pharma for $187 million
09:37 AM | August 6, 2014 | Natasha Alperowicz
Alvogen (Pine Brook, NJ), a privately owned pharmaceuticals company focused on developing, manufacturing, and distributing generic, OTC, and biosimilar products, announced today that it is acquiring...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.